Extrawell Pharmaceutical Expects Major Loss

Extrawell Pharmaceutical Holdings Limited (HK:0858) has released an update.

Extrawell Pharmaceutical Holdings Limited has issued a profit warning, alerting shareholders and potential investors that the company anticipates a significant loss for the financial year ending March 31, 2024, in contrast to the previous year’s profit. The forecasted loss is estimated between HK$160 million and HK$165 million, mainly due to a non-cash loss from the fair value change of convertible bond investments. Investors are urged to exercise caution when dealing in the company’s shares.

For further insights into HK:0858 stock, check out TipRanks’ Stock Analysis page.